Join us! The Department of Radiation Oncology at the University of Toronto (UTDRO) is seeking Corporate Partners to support our shared mission of advancing the innovation and practice of the professions in Radiation Medicine. We believe that through these partnerships both the University and the Corporate Partner will benefit.
UTDRO offers four events for sponsorship, which are further outlined below.
Clinical and Experimental Radiobiology Course
Clinical and Experimental Radiobiology is a 5-day program that provides a comprehensive overview of radiation biology with a particular emphasis on aspects of direct relevance to the practice of radiation oncology.
Next Date: April 15-19, 2024, Final exam on April 26, 2024
Clinical and Experimental Radiobiology is a 5-day program that provides a comprehensive overview of radiation biology with a particular emphasis on aspects of direct relevance to the practice of radiation oncology. It addresses the molecular and cellular responses to radiation-induced damage that influence cell death in both tumors and normal tissues. Quantitation of radiation effects and the underlying biological basis for fractionation of radiotherapy and dose-response relationships in the clinic are covered in depth. The biological basis for current approaches to improve radiotherapy will be described including novel fractionation schemes, retreatment issues, targeting hypoxia, biological modifiers and combined radiotherapy/chemotherapy.
The program is delivered by an expert group of international faculty in radiation biology and radiation oncology. The program is designed primarily to address the needs of radiation oncology residents and physics residents who are in radiation oncology departments. In addition, the course will be valuable to new researchers in radiation biology and to radiation oncology fellows or practicing oncologists who recognize a lack of basic science or want to update their knowledge.
RTi3 Radiation Therapy Conference
RTi3 is Canada’s premier radiation therapy conference, as the scope and calibre of the program continue to set the bar for radiation therapist-led research across the country.
Next Date: March 22 - 23, 2024
Radiation Therapists are an integral component of the interdisciplinary team delivering Radiation Therapy to large numbers of cancer patients. The abilities and knowledge of these individuals not only influences the well-being of patients’ during the radiotherapy process, but their skills and the evidence base they acquire has significant impact on treatment effectiveness and morbidity following radiotherapy. Thus effective therapists must continue to develop unique and distinctive skill sets and clinical approaches, blending the precise application of sophisticated technology with the holistic stance of supportive care.
RTi3 is the only conference in Canada that focuses on the knowledge translation activities for research therapists. It has the goal to expose radiation therapists to exemplary international research in order to disseminate knowledge that will inform clinical care, professional practice and policies. Another important goal is to exchange scientific knowledge amongst clinical and research radiation therapists in the fields of education, research and clinical practice in a forum which will foster mentorship, collaboration and communication.
The scientific program is relevant to all radiation medicine professionals, but it has been primarily targeted to a radiation therapist audience. To date, registered attendees include therapists from all over Canada, the US, the UK, and a number of other areas of the world. These individuals are a vital mixture of therapist researchers, educators, administrators, clinicians (both treatment delivery and dosimetry), undergraduate and graduate students.
Target Insight Conference
Target Insight has been a mechanism to present targeted information, innovative research, and to guide the direction of clinical care for the radiation oncology community.
Next Date: TBD
The number of cancer cases has been increasing steadily and is projected to continue to rise at a rate of 2 to 3% per year. Roughly half of these patients will require radiation therapy in the course of their treatment. The Target Insight audience reflects the interdisciplinary profession that is involved in the treatment of these patients: Radiation Oncologists, Radiation Physicists and Radiation Therapists (~160 – 200 attendees per annum). These teams are responsible for the highly involved planning and delivery of the radiation therapy as well as ensuring that the emotional and physical needs of the patients are satisfied. Ensuring that this team is informed of leading practices and research not only influences the positive outcome of these patients during radiotherapy treatment but also has a significant impact on ensuring that treatments are evidence based, highly efficient, and reduce the burden on the healthcare system.
Target Insight has been a mechanism to present targeted information to the radiation oncology community. In the recent past, this included the best practice use of advanced technologies such as IMRT, VMAT, IGRT and brachytherapy.
|Bonus Package Deal ♦||RTi3||Radiobiology||Research Day||Alumni Events|
2024 Sponsorship Bonus Package Deals
|2024 Bonus Package Deals||Silver - $15,000||Gold - $20,000||Platinum - $30,000|
|Exhibitor Space Ad Location||x||✓||✓ = most viewed|
|Event Communications||small logo||large logo||large logo|
|Digital Program Collateral||half page||full page||full page|
|Free Standing Banner||1||1||2|